医学免疫学课件:补体与免疫性身边_第1页
医学免疫学课件:补体与免疫性身边_第2页
医学免疫学课件:补体与免疫性身边_第3页
医学免疫学课件:补体与免疫性身边_第4页
医学免疫学课件:补体与免疫性身边_第5页
已阅读5页,还剩17页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Complement System and Autoimmune Renal DiseasesOutlineIntroduction of the Complement SystemComplement and Primary Autoimmune Renal DiseasesMembranous NephropathyIgA NephropathyLupus NephritisC3 Glomerulopathy Treatment Introduction of the Complement SystemComplement System: Activation and Regulation

2、BIRMINGHAM D J, HEBERT L A. Semin Nephrol, 2015, 35(5): 444-54.Complement andAutoimmune Kidney DiseasesComplement and Autoimmune Kidney DiseasesAntibody-Initiated Activation of ComplementMembranous NephropathyIgA NephropathyLupus NephritisImpaired Complement RegulationC3 GlomerulopathyMembranous Nep

3、hropathy: IntroductionMajor cause of Nephritic Syndrome2nd or 3th leading cause of end-stage renal diseasePresenting in older demographic groupCharacteristicsThickening of the glomerular capillary walls on light microscopyImmune deposits on the glomerular basement membraneMembranous Nephropathy: Imm

4、une ComplexBeck LH Jr et al. N Engl J Med 2009;361:11-21.Target antigen: M-Type Phospholipase A2 ReceptorAntibody subclass:IgG4Complement components in immune deposits and urine:Membranous Nephropathy: Complement ActivationMBL pathwayMBL can bind N-linked sugars on IgG that do not have terminal gala

5、ctoseAge , hypogalactosylated IgG Alternative Pathway: Loss of HS chains from the GBMBIRMINGHAM D J, HEBERT L A. Semin Nephrol, 2015, 35(5): 444-54.BORZA D-B. Frontiers in Immunology, 2016, 7(157)IgA Nephropathy: IntroductionLeading form of primary glomerulonephritisRecurred in 9-61% of transplanted

6、 patientsCharacteristicsMicroscopic hematuria and proteinuriaMesangial cell proliferation with IgA depositionMAGISTRONI R et al. Kidney international, 2015, 88(5): 974-89.IgA Nephropathy: PathogenesisMAGISTRONI R et al. Kidney international, 2015, 88(5): 974-89.ROBERT T et al. Trends in molecular me

7、dicine, 2015, 21(12): 762-75IgA Nephropathy: Complement ComponentsBIRMINGHAM D J, HEBERT L A. 2015, 35(5): 444-54.IgA Nephropathy: Complement ActivationAlternative pathwayComplement regulator: factor H and factor H related proteins (CFHR)Genetic variants: CFH, CFHR3, CFHR1MBL pathwayAberrant O-linke

8、d glycosylation of IgA1Associated with MALT: SIgA co-localized with MBLMore severeLi Zhu et al. JASN 2015;26:1195-1204Lupus Nephritis: IntroductionAssociated with systemic lupus erythematosus (SLE)60% of adults with SLEMost important predictor of mortality in patients with SLEEncompassed various pat

9、terns of renal diseasesglomerular pathologytubulointerstitial pathologyLupus Nephritis: Contradictory roles of complementComplement-mediated protectionClassic pathway: clearance of cellular debris, deficiency is the strongest genetic factor for SLEMake immune complex smaller: less pathogenicErythroc

10、yte CR1: immune adherence, preventing abnormal deposition of immune complexLupus Nephritis: Contradictory roles of complementComplement-mediated renal injuriesClassical pathwayExcess immune complex formationAnti-C1q: enhancing activationAlternative pathwayLower C3 levels: marker of flareProteinuria

11、cause activation with the tubular lumen: MAC on brush borderBIRMINGHAM D J, HEBERT L A. Semin Nephrol, 2015, 35(5): 444-54.C3 Glomerulopathy: IntroductionComplement-mediated Membranoproliferative Glomerulonephritis1-2 case per million inhabitantsCharacteristicsGlomerular C3 stainingabsent immunoglob

12、ulinsNORIS M, REMUZZI G. Am J Kidney Dis, 2015, 66(2): 359-75.C3 Glomerulopathy: Alternative Pathway OveractivationZIPFEL P F et al. Mol Immunol, 2015, 67(1): 21-30.BIRMINGHAM D J, HEBERT L A. 2015, 35(5): 444-54.TreatmentTreatmentInhibit Complement ActivationAnti-C5 antibody: EcuilizumabAnti-factor

13、 B monoclonal antibodiesCorrect dysregulationBinding complement inhibitor to the sites of activation: CR2-fHProviding factor H:infusion of fresh frozen plasmaConclusionImmune ComplexComplement Pathway OveractionComplement Regulatoractivatefail to inhibitRenal InjuriesReferencesBIRMINGHAM D J, HEBERT

14、 L A. The Complement System in Lupus Nephritis J. Semin Nephrol, 2015, 35(5): 444-54.RONCO P, DEBIEC H. Pathophysiological advances in membranous nephropathy: time for a shift in patients care J. Lancet (London, England), 2015, 385(9981): 1983-92.MATHERN D R, HEEGER P S. Molecules Great and Small: T

15、he Complement System J. Clinical journal of the American Society of Nephrology : CJASN, 2015, 10(9): 1636-50.BORZA D-B. Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy J. Frontiers in Immunology, 2016, 7(157)MA H, SANDOR

16、 D G, BECK L H, JR. The role of complement in membranous nephropathy J. Semin Nephrol, 2013, 33(6): 531-42.ROBERT T, BERTHELOT L, CAMBIER A, et al. Molecular Insights into the Pathogenesis of IgA Nephropathy J. Trends in molecular medicine, 2015, 21(12): 762-75GHARAVI A G, KIRYLUK K, CHOI M, et al.

17、Genome-wide association study identifies susceptibility loci for IgA nephropathy J. Nat Genet, 2011, 43(4): 321-7.MAGISTRONI R, DAGATI V D, APPEL G B, et al. New developments in the genetics, pathogenesis, and therapy of IgA nephropathy J. Kidney international, 2015, 88(5): 974-89.ZHU L, ZHAI Y L, W

18、ANG F M, et al. Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy J. J Am Soc Nephrol, 2015, 26(5): 1195-204.WYATT R J, JULIAN B A. IgA nephropathy J. The New England journal of medicine, 2013, 368(25): 240

19、2-14.GHARAVI A G, KIRYLUK K, CHOI M, et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy J. Nat Genet, 2011, 43(4): 321-7.DAHA M R, VAN KOOTEN C. Role of complement in IgA nephropathy J. J Nephrol, 2016, 29(1): 1-4.ROOS A, RASTALDI M P, CALVARESI N, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease J. J Am Soc Nephrol, 2006, 17(6): 1724-34.ESPINOSA M, ORTEGA R, SANCHEZ M, et al. Association of C4d deposition with clinical outcomes in IgA nephropathy J. Clinical journal of the A

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论